Meyahealth
HomeGeneticsGeneTHAP1 gene
Back to Gene
THAP1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

THAP1 gene

The THAP1 gene provides instructions for a transcription factor that regulates gene activity and plays a role in cell growth and programmed cell death.

Normal Function

The THAP1 gene provides instructions for a transcription factor, a protein that attaches to specific regions of DNA to regulate the activity of other genes. This protein helps control the growth and division (proliferation) of endothelial cells, which line blood and lymphatic vessels. Additionally, the THAP1 protein plays a role in apoptosis, the process of self-destruction for cells that are no longer needed.

Health Conditions Related to Genetic Changes

Dystonia 6

More than 70 mutations in the THAP1 gene have been identified in individuals with dystonia 6. This condition is part of a group of disorders characterized by involuntary movements, muscle tensing, twisting (torsion), and unusual positioning of body parts.

Most mutations associated with dystonia 6 either change single amino acids in the THAP1 protein or create a premature stop signal, resulting in an abnormally short protein. These mutations often affect the stability of the protein or its ability to bind to DNA. When the protein cannot bind to the correct regions of DNA, the regulation of gene activity is disrupted, leading to the symptoms of the condition.

Mutations that affect the DNA-binding region of the THAP1 protein generally result in more severe signs and symptoms compared to mutations in other regions of the protein.

Frequently Asked Questions

THAP1‑related dystonia is usually inherited in an autosomal‑dominant pattern, meaning a single altered copy of the gene can cause disease. Each child of an affected parent has a 50 % chance of inheriting the mutation. However, penetrance is variable—some carriers develop noticeable dystonia while others may have very mild or no symptoms. Genetic counseling is recommended to discuss personal and family risk, as well as options such as prenatal or pre‑implantation testing if desired.
Sudden worsening of muscle spasms that interfere with breathing, swallowing, or speech warrants immediate evaluation. New onset of severe neck or trunk rigidity that limits movement or causes pain should also prompt urgent review, as it may signal a complication such as respiratory compromise or injury from falls. If you notice rapid progression despite stable medication doses, contact your neurologist promptly.
targeted sequencing panel for movement‑disorder genes or a whole‑exome test that includes THAP1 can identify point mutations, small deletions, or premature stop codons. Blood is the most common specimen; no fasting or medication changes are usually required. Provide a detailed family history to the laboratory, and ask whether the report will include interpretation of variants of uncertain significance, which are common in THAP1 testing.
Currently, no therapy directly corrects the THAP1 defect. Management focuses on symptom control: oral medications (e.g., anticholinergics, baclofen), botulinum toxin injections for focal dystonia, and deep brain stimulation for severe generalized forms. Ongoing research into gene‑silencing and protein‑stabilizing approaches is experimental and not yet clinically available.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ